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general population has been demonstrated for body size
[2] and serum cholesterol [3] and has beeen postulated
to be due to malnutrition [3]. We agree with Canavese
et al that a great deal of research is still necessary regard-
ing the biological mechanisms of homocysteine metabo-
lism in patients with ESRD and their relationship to
cardiovascular risk.
The finding of differing TT genotype prevalence over
years of dialysis reported in these two studies is not irrec-
onciliable. There may be other differences in the design
of the studies that might explain variable risk estimates,
including clinical status, sample size, measurement issues,
Fig. 1. Time trends in evolution of lean body mass (LBM) after switchand race/ethnicity composition. We intend to examine
from conventional to daily hemodialysis in 7 patients with a 12-monthfollow-up data from our study and agree that experience
follow-up. It significantly increased within the first 6 months (P 0.02),reported from other centers is greatly needed. and remained stable thereafter. Value at t0 represents the average
Routine screening of either homocysteine or genetics between the values obtained at times 3 and 0, respectively. Mean
weekly ( SEM) standard Kt/V [2] increased from 2.22  0.13 atin not routinely recommended. A professional organiza-
baseline to 3.25  0.20 at 12 months (P  0.001).tion weighing the merits of such a clinical policy should
take into consideration the cost-effectiveness of the test
and associated interventions. In our clinic, the costs of
such tests are significantly lower than those mentioned
Fourteen volunteer patients were evaluated during 3by Canavese et al.
months on CHD and 12 months on DHD. The lean
body mass was evaluated at 3, 0, 6 and 12 months,Elizabeth M. Wrone, James L. Zehnder,
John M. Hornberger, Linda M. McCann, respectively. Five patients were excluded (renal trans-
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months) was analysed by ANOVA for repeated mea-
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Based on these observations, a switch to DHD could
be proposed to CHD patients with poor nutritional sta-
tus. Further studies, including a larger number of pa-
tients, are required to confirm these encouraging results.
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REFERENCES tion products correlated with markers of immune activa-
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even when dietary folate is within the recommended
range [2]. In coronary artery disease, folate supplemen-
tation was found to improve endothelial function earlier
than changes of homocysteine concentrations became
apparent [4], and also the data of Mezzano et al support
the view that hyperhomocysteinemia is an indirect conse-
quence of hyperconsumption of antioxidant vitamins dur-Moderate
ing prolonged states of immune activation. Then, hyper-
homocysteinemia is not primary in the pathogenesis ofhyperhomocysteinemia
vascular lesions and thrombotic events. Nevertheless,
hyperhomocysteinemia still could contribute to acceler-and oxidative stress
ate the underlying pathogenic process.
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